Lipid-lowering activity of Phacelia Tanacetifolia Benth. Extract in an experimental model of alcoholic liver damage
- 作者: Sheykhmagomedova P.A.1, Popov I.V.1, Sergeeva E.O.1, Popova O.I.1, Abisalova I.L.1, Sajaya L.A.1
-
隶属关系:
- Pyatigorsk Medical and Pharmaceutical Institute – Branch of Volgograd State Medical University of the Ministry of Health of the Russian Federation
- 期: 卷 28, 编号 5 (2025)
- 页面: 83-89
- 栏目: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/687967
- DOI: https://doi.org/10.29296/25877313-2025-07-10
- ID: 687967
如何引用文章
详细
Introduction. Expansion of the domestic raw material base is necessary and expedient due to the study of new plants, including foreign plants. Earlier it was established that the thick extract of the herb of phacelia tanacetifolia has hypolipidemic effect. Evaluation of the effectiveness of this plant substance in this aspect has an important medical and social significance, because lipid metabolism disorders and elevated cholesterol levels are the main risk factors for the development of cerebral ischemia.
The aim of the study is study of hypolipidemic activity of thick extract of phacelia tanacetifolia in conditions of experimental hyperlipidemia induced by ethanol.
Material and methods. The research of hypolipidemic activity was carried out on 20 white Wistar rats weighting 250–270 g. Researched extract was introduced in the form of an aqueous suspension. On the 10th day animals were injected intragastrically once with ethyl alcohol in the form of 40% aqueous solution at a dose of 5 g/kg (in terms of absolute ethanol). Nicotinic acid (Pharmstandard OJSC-UfaVita; Russia) at a dose of 25 mg/kg by the oral route of administration was used as a comparison drug, taking into account the conversion of the maximum daily dose of human to rat using an interspecies coefficient of 5.9. Triglycerides and cholesterol were analyzed on a biochemical analyzer RAL GLIMA MC-15 using reagents from DiaSys, manufactured in Germany.
Results. The introduction of the extract at a dose of 300 mg/kg reduced the content of triglycerides in rat serum by 46%, which may be due to inhibition of their synthesis in the liver; the comparison drug at a dose of 25 mg/kg reduced in serum by 54% and in liver by 68%. Regarding cholesterol, a reduction of 25% in serum and 27% in liver was observed when the extract was administered at a dose of 300 mg/kg and 33% and 20% when the comparison drug was administered. It was also found that under the influence of the extract there was a complete normalization of active thiobarbituric acid products in blood and liver, and liver diene conjugates.
Conclusions. Preventive use of extract in a model of acute hyperlipidemia induced by ethanol demonstrates a hypolipidemic effect due to a decrease in triglycerides and total cholesterol in serum and liver homogenate. An essential role in the prevention of hyperlipidemia plays antioxidant activity of the extract, manifested in the reduction of thiobarbituric acid active products in the liver and serum and diene conjugates in the liver, and increase in the redox potential of the glutathione system.
全文:

作者简介
P. Sheykhmagomedova
Pyatigorsk Medical and Pharmaceutical Institute – Branch of Volgograd State Medical University of the Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: Patya16101998@yandex.ru
ORCID iD: 0009-0002-3251-5562
SPIN 代码: 7724-1154
Post-graduate Student, Department of Pharmacognosy, Botany and Phytopreparation Technology
俄罗斯联邦, Kalinin Ave, 11, Pyatigorsk, 357532I. Popov
Pyatigorsk Medical and Pharmaceutical Institute – Branch of Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: beegeeslover@mail.ru
ORCID iD: 0009-0002-1163-057X
SPIN 代码: 3485-5858
Ph.D. (Pharm.), Associate Professor, Department of Pharmacognosy, Botany and Phytopreparation Technology
俄罗斯联邦, Kalinin Ave, 11, Pyatigorsk, 357532E. Sergeeva
Pyatigorsk Medical and Pharmaceutical Institute – Branch of Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: maklea@yandex.ru
ORCID iD: 0000-0001-7496-3967
SPIN 代码: 2945-9214
Ph.D. (Pharm.), Associate Professor, Head of the Department of Microbiology and Immonology
俄罗斯联邦, Kalinin Ave, 11, Pyatigorsk, 357532O. Popova
Pyatigorsk Medical and Pharmaceutical Institute – Branch of Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: beegeeslover@mail.ru
ORCID iD: 0009-0004-8235-073X
SPIN 代码: 8975-5891
Dr.Sc. (Pharm.), Full Professor, Department of Pharmacognosy, Botany and Phytopreparation Technology
俄罗斯联邦, Kalinin Ave, 11, Pyatigorsk, 357532I. Abisalova
Pyatigorsk Medical and Pharmaceutical Institute – Branch of Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: maklea@yandex.ru
ORCID iD: 0000-0002-3828-6759
SPIN 代码: 5373-9962
Ph.D. (Pharm.), Acting Head of the Department of Pathology
俄罗斯联邦, Kalinin Ave, 11, Pyatigorsk, 357532L. Sajaya
Pyatigorsk Medical and Pharmaceutical Institute – Branch of Volgograd State Medical University of the Ministry of Health of the Russian Federation
Email: maklea@yandex.ru
ORCID iD: 0000-0002-8382-0308
SPIN 代码: 3083-3288
Ph.D. (Pharm.), Associate Professor, Department of Pathology
俄罗斯联邦, Kalinin Ave, 11, Pyatigorsk, 357532参考
- Gribkova E., Pak T., Sobolenko D., Obivalina M. Istoricheskie aspekty i perspektivy razvitiya rossijskogo farmacevticheskogo rynka fitopreparatov. International Independent Scientific Journal. 2020; 12-1(12): 44–46. (In Russ.).
- Tokareva M.G., Prozhogina Yu.E., Kalenikova E.I., Dzhavahyan M.A. Analiz assortimenta rossijskogo rynka lekarstvennyh rastitelnyh preparatov sedativnogo dejstviya. Voprosy obespecheniya kachestva lekarstvennyh sredstv. 2019; 2(24): 4–19. (In Russ.).
- Yanovskaya E.A., Frelih G.A., Lakeev A.P., Yanovskij V.A. Farmakokinetika digidrokvercetina posle odnokratnogo i povtornogo vvedeniya krysam. Byulleten eksperimentalnoj biologii i mediciny. 2023; 176(12): 715–718. (In Russ.).
- Shaito A., Thuan D.T.B., Phu H.T. et al. Herbal medicine for cardiovascular diseases: effi cacy, mechanisms, and safety. Front. Pharmacol. 2020 Apr 7; 11: 422. doi: 10.3389/fphar.2020.00422.
- Das A., Baidya R., Chakraborty T., Samanta A.K., Roy S. Pharmacological basis and new insights of taxifolin: A comprehensive review. Biomed. Pharmacother. 2021 Oct; 142: 112004. doi: 10.1016/j.biopha.
- Shejhmagomedova P.A., Popova O.I. Identifikaciya fenolnyh soedinenij i razrabotka metodiki kolichestvennogo opredeleniya summy fenolkarbonovyh kislot v trave facelii piozhmolistnoj (Phacelia tanacetifolia Benth.). Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2022; 25(12): 44–50. (In Russ.).
- Vasileva L.V., Savova M.S., Amirova K.M. et al. Caffeic and Chlorogenic Acids Synergistically Activate Browning Program in Human Adipocytes: Implications of AMPK- and PPAR-Mediated Pathways. Int J Mol Sci. 2020; 21(24): 9740. doi: 10.3390/ijms21249740.
- Wang Z., Lam K.L., Hu J., Ge S. et al. Chlorogenic acid alleviates obesity and modulates gut microbiota in high-fat-fed mice. Food Sci Nutr. 2019; 7(2): 579–588. doi: 10.1002/fsn3.868.
- Shejhmagomedova P.A., Sergeeva E.O., Abisalova I.L. i dr. Gipolipidemicheskaya aktivnost fitokompleksa travy facelii pizhmolistnoj (Phacelia tanacetifolia Benth.). Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2024; 27(1): 69–74. (In Russ.).
- Bibik E.Yu., Shipilova N.V., Krivkolysko B.S. i dr. Osobennosti farmakologicheskih svojstv sovremennyh gepatoprotektorov. Morfologicheskij almanah imeni V.G. Koveshnikova. 2019; 17(4): 101–110. (In Russ.).
- Mizina P.G., Lupanova I.A., Karabaeva V.V. i dr. Lekarstvennye rasteniya s obsheukreplyayushej i toniziruyushej aktivnostyu, proizrastayushie v Respublike Buryatiya (obzor). Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2024; 27(1): 3–14. (In Russ.).
- Ferubko E.V., Dargaeva T.D., Nikolaev S.M. Eksperimentalnaya farmakoterapiya toksicheskogo gepatita rastitelnym ekstraktom. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii. 2019; 22(6): 3–8. (In Russ.).
- Jeon S., R. Carr. Alcohol effects on hepatic lipid metabolism. J. Lipid Res. 2020; 61: 470–479.
- Ratkin A.V., Kajdash O.A., Pfarger Yu.A. i dr. Gipolipidemicheskoe dejstvie seskviterpenovyh laktonov arglabina i ahillina na modeli ostroj giperlipidemii. Sibirskoe medicinskoe obozrenie. 2014; 5(89): 40–43. (In Russ.).
- Ratkin A.V., Kajdash O.A., Ivanov V.V. i dr. Effektivnost lyudartina i leukomizina pri ostroj eksperimentalnoj giperlipidemii, inducirovannoj etanolom. Byulleten sibirskoj mediciny. 2015; 14(4): 54–59. (In Russ.).
- Rodnova E.A. Mehanizmy gipolipidemicheksogo dejstviya seskviterpenovogo laktona leukomizina: avtoreferat dissertacii na soiskanie uchenoj stepeni kandidata biologicheskih nauk. M.; 1997; 98 s. (In Russ.).
- Karkishenko N.N. Alternativy biomediciny. T.2. Klassika i alternativy farmakotoksikologii. M.: Izd-vo VPK. 2007; 448 s. (In Russ.).
- Karkishenko N.N. Alternativy biomediciny. T.1. Osnovy biomediciny i farmakomodelirovaniya. M.: Izd-vo VPK. 2007; 319 s. (In Russ.).
- Gubich O.I., Dashkova Ya.Yu., Krivlenya I.N. Sravnitelnaya ocenka gepatoprotektornyh svojstv rastitelnyh adaptogenov na eksperimentalnoj modeli hronicheskogo alkogolnogo porazheniya pecheni in vivo. Zhurnal Belorusskogo gosudarstvennogo universiteta. Biologiya. 2019; 1: 54–62. doi: 10.33581/2521-1722-2019-1-54-62. (In Russ.).
补充文件
